Amyotrophic Lateral Sclerosis (ALS) Animal Models & CRO Services

Amyotrophic lateral sclerosis (ALS, Lou Gehrig's Disease) is a progressive neurodegenerative disease resulting in generalized muscle weakness and atrophy, and, usually, death within a few years. In the U.S., approximately 10,000 patients are newly diagnosed with ALS each year. The disease strikes men and women of all ages.

Amyotrophic lateral sclerosis (ALS, Lou Gehrig's Disease) is a progressive neurodegenerative disease resulting in generalized muscle weakness and atrophy, and, usually, death within a few years. In the U.S., approximately 10,000 patients are newly diagnosed with ALS each year. The disease strikes men and women of all ages.

NeuroVasc has considerable experience in the use of this SOD-1 mutant transgenic mouse model to test possible new treatments for both sporadic and familial ALS. This transgenic mouse strain also serves as a general model of neurodegenerative diseases and neurodegenerative treatments. Endpoints are animal survival, behavior, and histology.

Your partner for preclinical CNS and Vascular models

Newsletter

 

Contact Us

NeuroVasc Preclinical Services, Inc.
3 Forbes Road
Lexington MA 02421

617-855-6289

info@neurovascps.com